Supplemental Figure 3

Published: 22 August 2024| Version 1 | DOI: 10.17632/nfftvjy5mh.1
Contributor:
eden axler

Description

Supplemental Figure 3: Fitzpatrick skin type II, fragile nails after treatment with estrogen modulator examestane for breast cancer. Fingernails show onychoschizia at the distal edge.

Files

Categories

Nail Abnormality

Licence